Plasma dimethylglycine, nicotine exposure and risk of low bone mineral density and hip fracture: the Hordaland Health Study
- 308 Downloads
In the large community-based Hordaland Health Study, low plasma dimethylglycine was associated with low bone mineral density in both middle-aged and elderly subjects and to an increased risk of subsequent hip fracture among the elderly. These associations seemed to be particularly strong among subjects exposed to nicotine.
Dimethylglycine (DMG) is a product of the choline oxidation pathway and formed from betaine during the folate-independent remethylation of homocysteine (Hcy) to methionine. Elevated plasma DMG levels are associated with atherosclerotic cardiovascular disease and inflammation, which in turn are related to osteoporosis. High plasma total Hcy and low plasma choline are associated with low bone mineral density (BMD) and hip fractures, but the role of plasma DMG in bone health is unknown.
We studied the associations of plasma DMG with BMD among 5315 participants (46–49 and 71–74 years old) and with hip fracture among 3310 participants (71–74 years old) enrolled in the Hordaland Health Study.
In age and sex-adjusted logistic regression models, subjects in the lowest versus highest DMG tertile were more likely to have low BMD (odds ratio [OR] 1.68, 95 % confidence interval [CI] 1.43–1.99). The association was stronger in participants exposed compared to those unexposed to nicotine (OR 2.31, 95 % CI 1.73–3.07 and OR 1.43, 95 % CI 1.16–1.75, respectively, p interaction = 0.008). In the older cohort, Cox regression analyses adjusted for sex showed that low plasma DMG was associated with an increased risk of hip fracture (hazard ratio [HR] 1.70, 95 % CI 1.28–2.26). A trend toward an even higher risk was found among women exposed to nicotine (HR 3.41, 95 % CI 1.40–8.28).
Low plasma DMG was associated with low BMD and increased risk of hip fractures. A potential effect modification by nicotine exposure merits particular attention.
KeywordsBone mineral density Dimethylglycine Hip fracture Nicotine exposure One-carbon metabolism Smoking
Conflicts of interest
- 19.Schartum-Hansen H, Pedersen ER, Svingen GF, Ueland PM, Seifert R et al (2014) Plasma choline, smoking, and long-term prognosis in patients with stable angina pectoris. Eur J Prev Cardiol. doi: 10.1177/2047487314524867
- 26.Midttun O, Townsend MK, Nygard O, Tworoger SS, Brennan P et al (2014) Most blood biomarkers related to vitamin status, one-carbon metabolism, and the kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovascular patients. J Nutr 144:784–790CrossRefPubMedGoogle Scholar
- 31.Team RC (2013) R: a language and environment for statistical computing. R Development Core Team, Vienna, AustriaGoogle Scholar
- 33.Norwegian Institute of Public Health (2010) Smoking and smokeless tobacco in Norway - fact sheet. http://www.fhi.no/artikler/?id=84434
- 41.Svingen GF, Schartum-Hansen H, Ueland PM, Pedersen ER, Seifert R et al (2014) Elevated plasma dimethylglycine is a risk marker of mortality in patients with coronary heart disease. Eur J Prev Cardiol. doi: 10.1177/2047487314529351
- 42.Stunes AK, Westbroek I, Gustafsson BI, Fossmark R, Waarsing JH et al (2011) The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats. BMC Endocr Disord 11:11CrossRefPubMedCentralPubMedGoogle Scholar
- 44.Wang L, Chen L, Tan Y, Wei J, Chang Y et al (2013) Betaine supplement alleviates hepatic triglyceride accumulation of apolipoprotein E deficient mice via reducing methylation of peroxisomal proliferator-activated receptor alpha promoter. Lipids Health Dis 12:34CrossRefPubMedCentralPubMedGoogle Scholar